D Ruiz-Sánchez1, L Calderón-Romero, J T Sánchez-Vega, J Tay. 1. Laboratory of Parasitology, Department of Microbiology and Parasitology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico. letycr@servidor.unam
Abstract
UNLABELLED: An eight-years-old girl, who presented with recurrent upper respiratory tract infections, was treated with broad-spectrum antibiotics. Afterward she presented with intestinal candidiasis. The isolated species was identified as Candida albicans by differential tests. Treatment given was with 500,000 IU of oral nystatin every 8 hours for 10 days and intestinal normal microbiota restoratives. Evolution has been satisfactory, although concomitantly type A hepatitis developed. Rest and a soft diet were recommended. The child is now perfectly healthy with normal liver function tests. CONCLUSION: Prolonged treatments with broad-spectrum antibiotics destroyed the indigenous intestinal microbiota, which provoked intestinal C. Albicans proliferation and adversely affected the immunological system of the patient, thus facilitating the establishment of a viral infection.
UNLABELLED: An eight-years-old girl, who presented with recurrent upper respiratory tract infections, was treated with broad-spectrum antibiotics. Afterward she presented with intestinal candidiasis. The isolated species was identified as Candida albicans by differential tests. Treatment given was with 500,000 IU of oral nystatin every 8 hours for 10 days and intestinal normal microbiota restoratives. Evolution has been satisfactory, although concomitantly type A hepatitis developed. Rest and a soft diet were recommended. The child is now perfectly healthy with normal liver function tests. CONCLUSION: Prolonged treatments with broad-spectrum antibiotics destroyed the indigenous intestinal microbiota, which provoked intestinal C. Albicans proliferation and adversely affected the immunological system of the patient, thus facilitating the establishment of a viral infection.
Authors: R D Wagner; T Warner; C Pierson; L Roberts; J Farmer; M Dohnalek; M Hilty; E Balish Journal: Rev Iberoam Micol Date: 1998-12 Impact factor: 1.044
Authors: Katie L Mason; John R Erb Downward; Kelly D Mason; Nicole R Falkowski; Kathryn A Eaton; John Y Kao; Vincent B Young; Gary B Huffnagle Journal: Infect Immun Date: 2012-07-09 Impact factor: 3.441
Authors: Pim T van Leeuwen; Jasper M van der Peet; Floris J Bikker; Michel A Hoogenkamp; Ana M Oliveira Paiva; Sarantos Kostidis; Oleg A Mayboroda; Wiep Klaas Smits; Bastiaan P Krom Journal: mSphere Date: 2016-11-09 Impact factor: 4.389